lipoceutical glutathione bulletproof High Absorption Liposomal Liposomal Glutathione

Deoxycholic acid (DCA), a secondary BA, inhibits the plasma membrane Ca + ATPase (PMCA), suppressing Ca + -NFAT2 signaling and reducing cytotoxic molecules such as IFN-, TNF-, and granzyme B (GzmB), potentially impairing ICI efficacy when intratumoral DCA is high ( + T cell activation and cytokine production, and has been associated with improved ICI response in non-small cell lung cancer, possibly via enhanced memory CD8 + T cell formation ( + T cell infiltration and favorable outcomes ( + T cell infiltration and limits HCC progression ( The microbiota shapes the BA pool and influences CD8 + T cell function

449 YanX.TezelG.WaxM.EdwardD

Additional Product Information

doi: 10.1080/10408398.2021.1987858 109

Communication 3

In recent times, several nanoplatforms have been employed in cancer therapy, specifically chemodynamic therapy (CDT), by integrating endogenous and exogenous stimuli-responsive ROS production